SCHEMBL4279702

SCHEMBL4279702

COc1ccc(C(=O)c2c(O)cc(COC(C)=O)cc2F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP3A4 P08684 1/20 0.44
MAOB P27338 2/20 0.44
SLC5A1 P13866 1/20 0.44
SLC5A2 P31639 1/20 0.44
ALDH1A1 P00352 3/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
MAOA P21397 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
PGR P06401 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4279710 0.88 MAOB (0.48) NFKB1NFKB2RELAMAOBSLC5A1
SCHEMBL4292523 0.87 PARP10 (0.43) MAOBKMT2AMAOA
SCHEMBL4279701 0.86 CYP3A4 (0.54) NFKB1NFKB2RELACYP2D6CYP2C19
SCHEMBL4284273 0.86 SLC5A1 (0.47) MAOBSLC5A1SLC5A2ALDH1A1KMT2A
SCHEMBL4288666 0.85 KMT2A (0.46) NFKB1NFKB2RELACYP2D6CYP2C19
SCHEMBL4285302 0.85 HPGD (0.46) NFKB1NFKB2RELACYP2D6CYP2C19
SCHEMBL4287006 0.84 NFKB1 (0.46) NFKB1NFKB2RELACYP2D6CYP2C19
SCHEMBL38661406 0.82 CYP2D6 (0.54) NFKB1NFKB2RELACYP2D6CYP2C19
SCHEMBL4291912 0.80 NFKB1 (0.42) NFKB1NFKB2RELACYP3A4MAOB
SCHEMBL4285592 0.77 POLB (0.39) NFKB1NFKB2RELACYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101472937-A Benzylphenylglucopyranoside Derivatives DAIICHI SANKYO CO LTD (JP) 2009-07-01 CN disclosed
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 NFKB1 2608/4885NFKB2 1814/4885RELA 513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.